PRTA logo

Prothena (PRTA)

Profile

Full Name

Prothena Corporation plc

Ticker Symbol

PRTA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Ireland

IPO

December 18, 2012

Indexes

Not included

Website

http://www.prothena.com

Employees

163

Key Details

Price

$13.08

Market Cap

$704.05M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$135.16M(+47.92% YoY)

Annual EPS

-$2.27(+17.75% YoY)

PE Ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$13.08
PRTA price is $13.08

Price All-time High

$78.89
PRTA price is currently -83.42% below its historical high of $78.89

Price Most Recent Change

+0.54%
PRTA price was up +0.54% on Mar 28, 2025

Price YTD Change

+0.61%
PRTA price is up +0.61% since January 1st

Price 1-year Change

-47.13%
PRTA price is down -47.13% year-on-year

Price 3-year Change

-64.61%
PRTA price is down -64.61% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$704.05M
PRTA market capitalization is $704.05 million

Market Cap 3-year Change

-59.25%
PRTA market capitalization is down -59.25% over the past 3 years

Market Cap All-time High

$4.15B
PRTA market capitalization is currently -83.02% below its historical high of $4.15 billion

Market Cap Sector Rank

72.15%
PRTA market capitalization is higher than 72.15% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.2%
PRTA shares outstanding is up +0.2% year-on-year

Shares Outstanding 3-Year Change

+15.16%
PRTA shares outstanding is up +15.16% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.58
PRTA beta is 1.58

200-day SMA

$17.45
PRTA price is currently -25.04% below its 200-day simple moving average

50-day SMA

$14.30
PRTA price is currently -8.52% below its 50-day simple moving average

RSI

43.83
PRTA 14-day relative strength index is 43.83

Volume

0.44
PRTA 30-day relative volume is 0.44

ATR

$0.77
PRTA average true range is $0.77

10-day Historical Volatility

57.62%
PRTA 10-day historical volatility is 57.62%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$135.16M
PRTA annual revenue is $135.16 million

Revenue Analysts Estimate

$50.60M
PRTA annual revenue is currently +167.11% higher than the consensus analysts' forecast

Revenue 1-year Change

+47.92%
PRTA annual revenue is up +47.92% year-on-year

Revenue Sector Rank

59.28%
PRTA annual revenue is higher than 59.28% of companies in Healthcare sector

EPS

EPS

-$2.27
PRTA annual earnings per share is -$2.27

EPS Analysts Estimate

-$3.58
PRTA annual earnings per share is currently -36.67% lower than the consensus analysts' forecast

EPS 1-year Change

+17.75%
PRTA annual earnings per share is up +17.75% year-on-year

EPS Sector Rank

36.51%
PRTA annual earnings per share is higher than 36.51% of companies in Healthcare sector

Profit

Gross Profit

-
PRTA annual gross profit value is unknown

Gross Margin

-
PRTA annual gross profit margin value is unknown

Operating Profit

-$154.56M
PRTA annual operating income is -$154.56 million

Operating Margin

-114.36%
PRTA annual operating profit margin is -114.36%

Net Income

-$122.31M
PRTA annual net profit is -$122.31 million

Net Margin

-90.49%
PRTA annual net profit margin is -90.49%

Expenses

Total Expenses

$289.72M
PRTA annual total expenses is $289.72 million

Operating Expenses

$289.72M
PRTA annual total operating expenses is $289.72 million

Cost Of Goods Sold

-
PRTA annual cost of goods sold value is unknown

Selling, General & Administrative Expenses

$67.20M
PRTA annual SGA is $67.20 million

Depreciation And Amortization

$893.00K
PRTA annual depreciation & amortization is $893.00 thousand

Interest Expense

-
PRTA annual interest expense value is unknown

Income Tax

-$6.62M
PRTA annual income tax is -$6.62 million

EBIT & EBITDA

EBIT

-$154.56M
PRTA annual earnings before interest & taxes is -$154.56 million

EBITDA

-$154.56M
PRTA annual EBITDA is -$154.56 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$547.11M
PRTA annual total assets is $547.11 million

Non Current Assets

$61.70M
PRTA annual long term assets is $61.70 million

Current Assets

$485.41M
PRTA annual total current assets is $485.41 million

Cash And Cash Equivalents

$471.39M
PRTA annual cash & cash equivalents is $471.39 million

Accounts Receivable

$0.00
PRTA annual accounts receivable is $0.00

Inventory

-
PRTA annual inventory value is unknown

Liabilities

Total Liabilities

$60.18M
PRTA annual total liabilities is $60.18 million

Long Term Liabilities

$11.68M
PRTA annual total long term liabilities is $11.68 million

Current Liabilities

$48.50M
PRTA annual total current liabilities is $48.50 million

Accounts Payable

$7.77M
PRTA annual accounts payable is $7.77 million

Debt

Total Debt

$10.84M
PRTA annual total debt is $10.84 million

Total Debt 1-year Change

-8.38%
PRTA annual total debt is down -8.38% year-on-year

Long Term Debt

$8.23M
PRTA annual long term debt is $8.23 million

Short Term Debt

$2.61M
PRTA annual short term debt is $2.61 million

Equity & Capital

Shareholders Equity

$486.93M
PRTA annual stockholders equity is $486.93 million

Book Value

$486.93M
PRTA annual book value is $486.93 million

Retained Earnings

-$1.10B
PRTA annual retained earnings is -$1.10 billion

Working Capital

$436.91M
PRTA annual working capital is $436.91 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$150.05M
PRTA annual cash flow from operations is -$150.05 million

Cash From Operations 1-year Change

-12.06%
PRTA annual cash flow from operations is down -12.06% year-on-year

Cash From Investing

-$298.00K
PRTA annual cash flow from investing activities is -$298.00 thousand

Cash From Investing 1-year Change

+89.25%
PRTA annual cash flow from investing activities is up +89.25% year-on-year

Cash From Financing

$1.55M
PRTA annual cash flow from financing activities is $1.55 million

Cash From Financing 1-year Change

-96.55%
PRTA annual cash flow from financing activities is down -96.55% year-on-year

CAPEX

CAPEX

$298.00K
PRTA annual capital expenditures is $298.00 thousand

CAPEX 1-year Change

-89.4%
PRTA annual capital expenditures is down -89.4% year-on-year

Free Cash Flow

Free Cash Flow

-$150.35M
PRTA annual free cash flow is -$150.35 million

Free Cash Flow 1-year Change

-9.97%
PRTA annual free cash flow is down -9.97% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

-
PRTA annual gross profit margin value is unknown

Operating Margin

-114.36%
PRTA annual operating profit margin is -114.36%

Net Margin

-90.49%
PRTA annual net profit margin is -90.49%

ROA & ROE

ROA

-19.67%
PRTA annual return on assets is -19.67%

ROE

-23.34%
PRTA annual return on equity is -23.34%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
PRTA price to earnings ratio value is unknown

PE Ratio Sector Rank

-
PRTA price to earnings ratio is unknown

PB Ratio

PB Ratio

1.45
PRTA price to book ratio is 1.45

PB Ratio Sector Rank

51.86%
PRTA price to book ratio is higher than 51.86% of companies in Healthcare sector

PS Ratio

PS Ratio

5.21
PRTA price to sales ratio is 5.21

PS Ratio Sector Rank

65.84%
PRTA price to sales ratio is higher than 65.84% of companies in Healthcare sector

Enterprise value

Enterprise Value

$243.51M
PRTA enterprise value is $243.51 million

Enterprise Value Sector Rank

59.62%
PRTA enterprise value is higher than 59.62% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.58
PRTA EV/EBITDA is -1.58

EV/EBITDA Sector Rank

37.94%
PRTA EV/EBITDA is higher than 37.94% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

10.01
PRTA annual current ratio is 10.01

Quick Ratio

-
PRTA annual quick ratio value is unknown

Leverage

Debt To Equity

0.00
PRTA annual debt to equity ratio is 0.00

Interest Coverage Ratio

-
PRTA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
PRTA piotroski f-score value is unknown

Altman Z-Score

4.47
PRTA altman z-score is 4.47

Analyst ratings

Recent major analysts updates

Feb 26, 25 Piper Sandler
Overweight
Feb 24, 25 HC Wainwright & Co.
Buy
Feb 21, 25 RBC Capital
Sector Perform
Feb 21, 25 HC Wainwright & Co.
Buy
Feb 21, 25 Citizens Capital Markets
Market Outperform
Feb 21, 25 Chardan Capital
Buy
Feb 21, 25 Cantor Fitzgerald
Overweight
Feb 7, 25 Oppenheimer
Outperform
Dec 20, 24 HC Wainwright & Co.
Buy
Dec 20, 24 Chardan Capital
Buy

Institutional Ownership

Similar stocks

LENZ logo
LENZ Therapeutics (LENZ)
EMBC logo
Embecta (EMBC)
CRON logo
Cronos (CRON)
Fortrea Holdings (FTRE)
GHRS logo
GH Research (GHRS)
ABCL logo
AbCellera Biologics (ABCL)
CVAC logo
CureVac NV (CVAC)
QURE logo
uniQure NV (QURE)
COGT logo
Cogent Biosciences (COGT)
  • What is the ticker symbol for Prothena?
  • Does Prothena pay dividends?
  • What sector is Prothena in?
  • What industry is Prothena in?
  • What country is Prothena based in?
  • When did Prothena go public?
  • Is Prothena in the S&P 500?
  • Is Prothena in the NASDAQ 100?
  • Is Prothena in the Dow Jones?
  • When was Prothena's last earnings report?
  • When does Prothena report earnings?
  • Should I buy Prothena stock now?

What is the ticker symbol for Prothena?

The ticker symbol for Prothena is NASDAQ:PRTA

Does Prothena pay dividends?

No, Prothena does not pay dividends

What sector is Prothena in?

Prothena is in the Healthcare sector

What industry is Prothena in?

Prothena is in the Biotechnology industry

What country is Prothena based in?

Prothena is headquartered in Ireland

When did Prothena go public?

Prothena's initial public offering (IPO) was on December 18, 2012

Is Prothena in the S&P 500?

No, Prothena is not included in the S&P 500 index

Is Prothena in the NASDAQ 100?

No, Prothena is not included in the NASDAQ 100 index

Is Prothena in the Dow Jones?

No, Prothena is not included in the Dow Jones index

When was Prothena's last earnings report?

Prothena's most recent earnings report was on Feb 20, 2025

When does Prothena report earnings?

The next expected earnings date for Prothena is May 8, 2025

Should I buy Prothena stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page